Additional European Equity News
Ahold Delhaize (AD NA) - Co. plans to name Thierry Garnier as CEO in 2027. (Ahold Delhaize)
ASML (ASML NA) - Exec says he thinks hyperscalers would tell people that for the next two/three/five years, they are not going to get enough chips. Notes China EUV plans are making little progress. (ASML)
Adyen (ADYEN NA) - Q1 2026 (EUR): Net revenue 620.8mln (exp. 621.6mln, prev. 535.5mln Y/Y), Processed volume 382.0bln. 2026 guidance for net revenue growth 20-22% constant FX and EBITDA margin broadly in line with 2025. (Adyen)
DSM-Firmenich (DSFIR NA) - Q1 2026 (EUR): Sales 2.28bln (exp. 2.24bln), Adj. EBITDA 434mln (exp. 434.9mln). 4% LFL sales growth, with strong performance in Perfumery & Beauty. €500 million share buyback for capital reduction, launched March 12, 2026. FY 2026 outlook maintained. (DSM-Firmenich)
Diageo (DGE LN) - Q3 2026 (USD): Net Sales 4.47bln (prev. 4.37bln Y/Y). Strong organic net sales growth was delivered in Europe, LAC and Africa with some benefit from Easter timing and advance sales ahead of the upcoming FIFA World Cup. In North America, organic net sales declined high-single-digit reflecting continued US Spirits weakness. FY26 guidance unchanged. (Diageo)
Daimler Truck (DTG GY) - Q1 2026 (EUR): Adj. EBIT 498mln (prev. 1.08bln Y/Y), Revenue 10bln (prev. 10.1bln). Affirms guidance. (Daimler Truck)
JD Wetherspoon (JDW LN) - Trading Update: Like-for-like sales increased by 3.4% in the 13 weeks to 26 April 2026. CEO: "As many hospitality operators, including Wetherspoon, have reported, there have been substantial increases in costs, which may result in profits slightly below market expectations". (JD Wetherspoon)
Kingfisher (KGF LN) - CEO resigns, and search for new replacement is underway. (Kingfisher)
Novo Nordisk’s (NOVOB DC) - CEO Doustdar says we do not see early dropouts of patients taking the Wegovy Pill. (Newswires)
Next (NXT LN) - Q1 2026 Trading Update: Full price sales +6.2% Y/Y, against our forecast for the period of +4.0%. Outlook: Increasing our guidance for the full year to GBP 1.2bln. We are maintaining our guidance for full price sales for the rest of the year. We plan to mitigate the ongoing cost increases caused by the conflict in the Middle East with a combination of moderate price increases in some international territories and operational cost savings. (Next)
Orsted (ORSTED DC) - Q1 2026 (DKK): Revenue 27.6bln (exp. 23bln), EBITDA 9.545bln (prev. 8.871bln Y/Y), EBITDA excl. new partnerships and cancellation fees 9.545bln (prev. 8.567bln Y/Y), Net Income 2.621bln (prev. 4.887bln Y/Y), Operating Cash Flow 6.537bln (prev. 634mln Y/Y). FY guidance maintained for EBITDA above 28bln (exp. 29.3bln). (Orsted)
Smith & Nephew (SN/ LN) - Q1 2026 (USD): Revenue 1.5bln, +3.1% Y/Y (exp. +3.7%); co. to buyback USD 500mln in shares. Affirms FY26 guidance. Co. expects around USD 60mln impact from tariffs. (Smith & Nephew)
SBB (SBBB SS) - Q1 2026 (SEK): Rental income 474mln (prev. 473mln Y/Y), Net operating income 254mln (prev. 247mln Y/Y), Profit from property management incl. discontinued operations 131mln (prev. 81mln Y/Y).(SBB)
Veolia (VIE FP) - Q1 2025 (EUR): EBITDA 1.76bln (prev. 1.7bln Y/Y), Revenue 11.4bln (prev. 11.5bln Y/Y). Affirms FY guidance. (Veolia)
Wolters Kluwer (WKL NA) - Q1 2026 (EUR): Revenue +4% constant FX and +5% organic, Recurring revenue +7% organic, Cloud software revenue +14% organic, Adj. Operating Profit +11% constant FX, Adj. Free Cash Flow +15% constant FX. Net debt/EBITDA 1.9x, FY guidance reiterated. (Wolters Kluwer)
Nexans (NEX FP) resumed with Outperform at BNP Paribas